AVANIR PHARMACEUTICALS (AVNR)

[damoney]

sweet crude, many thanks for your valuable reasearch. And, at least now with the secondary offering out of the way retail investors don’t have to wonder about its effect on the pps. I would like to know how much of the secondary offering could be placed through large blocks directly into longer-term hands through their institutional placement desks and how much will actually will hit the retail market as this would dictate the daily pps until completed.
I will add more should it for any reason fall below the 4.40 mark.